GSK (NYSE:GSK) reported its Q4 earnings results on Wednesday, January 31, 2024 at 03:50 AM.
Here’s what investors need to know about the announcement.
Earnings
GSK missed estimated earnings by 4.27%, reporting an EPS of $0.718 versus an estimate of $0.75.
Revenue was up $1.41 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.2 which was followed by a 1.19% drop in the share price the next day.
Here’s a look at GSK’s past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 1.07 | 0.87 | 0.82 | 0.50 |
| EPS Actual | 1.27 | 0.97 | 0.90 | 0.61 |
| Revenue Estimate | 9.37B | 8.97B | 8.06B | 8.91B |
| Revenue Actual | 10.27B | 8.97B | 8.44B | 8.65B |
To track all earnings releases for GSK visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
